| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $38.8M | -21.7% | -56.4% |
| R&D Expense | $69.4M | +29.9% | -9.9% |
| SG&A Expense | $45.0M | +3.9% | -14.0% |
| Operating Income | -$90.0M | -37.3% | -63.1% |
| Pre-tax Income | -$80.8M | -33.3% | -42.2% |
| Income Tax | $1K | +100.4% | +100.3% |
| Net Income | -$80.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $111.1M | -45.4% | -82.0% |
| Short-term Investments | $384.4M | +8.0% | — |
| Accounts Receivable | $21.4M | -3.3% | -8.5% |
| Current Assets | $506.1M | -3.2% | -23.6% |
| Total Assets | $1.19B | -3.4% | -19.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$123.4M | — | — |
| Capital Expenditures | $7.7M | — | — |
| Investing Cash Flow | -$335.4M | — | — |
| Financing Cash Flow | $9.6M | — | — |
| Free Cash Flow | -$131.0M | — | — |
| -33.9% |
| -43.2% |
| EPS (Basic) | -$1.45 | -31.8% | -34.3% |
| EPS (Diluted) | -$1.45 | -31.8% | -34.3% |
| $115.3M |
| +19.2% |
| +0.7% |
| Total Liabilities | $629.4M | +1.8% | -7.8% |
| Stockholders' Equity | $559.8M | -8.7% | -29.8% |